- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Orphan Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Orphan Drugs market size is estimated to be worth US$ 126280 million in 2021 and is forecast to a readjusted size of USD 235070 million by 2028 with a CAGR of 9.3% during review period. Hospital Pharmacies accounting for % of the Orphan Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Oncology segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Orphan Drugs include Novartis, Bristol-Myers Squibb Company, Celgene, F. Hoffmann-La Roche, and Pfizer, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Orphan Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oncology
Gastrointestinal
Pulmonary
Neurology
Hematology
Cardio-vascular
Metabolic Disorders
Endocrinology
Infectious Diseases
Others
Market segment by Application can be divided into
Hospital Pharmacies
Retail pharmacies
Others
The key market players for global Orphan Drugs market are listed below:
Novartis
Bristol-Myers Squibb Company
Celgene
F. Hoffmann-La Roche
Pfizer
Sanofi
Alexion Pharmaceuticals
Eli Lilly and Company
Novo Nordisk
AstraZeneca
Eisai
Daiichi Sankyo Company
Bayer
GlaxoSmithKline
Merck & Co
Johnson & Johnson
Biogen
Takeda
Amgen
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Orphan Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Orphan Drugs, with price, sales, revenue and global market share of Orphan Drugs from 2019 to 2022.
Chapter 3, the Orphan Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Orphan Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Orphan Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Orphan Drugs.
Chapter 13, 14, and 15, to describe Orphan Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Orphan Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Orphan Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Oncology
1.2.3 Gastrointestinal
1.2.4 Pulmonary
1.2.5 Neurology
1.2.6 Hematology
1.2.7 Cardio-vascular
1.2.8 Metabolic Disorders
1.2.9 Endocrinology
1.2.10 Infectious Diseases
1.2.11 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Orphan Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail pharmacies
1.3.4 Others
1.4 Global Orphan Drugs Market Size & Forecast
1.4.1 Global Orphan Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Orphan Drugs Sales in Volume (2017-2028)
1.4.3 Global Orphan Drugs Price (2017-2028)
1.5 Global Orphan Drugs Production Capacity Analysis
1.5.1 Global Orphan Drugs Total Production Capacity (2017-2028)
1.5.2 Global Orphan Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Orphan Drugs Market Drivers
1.6.2 Orphan Drugs Market Restraints
1.6.3 Orphan Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Orphan Drugs Product and Services
2.1.4 Novartis Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Bristol-Myers Squibb Company
2.2.1 Bristol-Myers Squibb Company Details
2.2.2 Bristol-Myers Squibb Company Major Business
2.2.3 Bristol-Myers Squibb Company Orphan Drugs Product and Services
2.2.4 Bristol-Myers Squibb Company Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Celgene
2.3.1 Celgene Details
2.3.2 Celgene Major Business
2.3.3 Celgene Orphan Drugs Product and Services
2.3.4 Celgene Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 F. Hoffmann-La Roche
2.4.1 F. Hoffmann-La Roche Details
2.4.2 F. Hoffmann-La Roche Major Business
2.4.3 F. Hoffmann-La Roche Orphan Drugs Product and Services
2.4.4 F. Hoffmann-La Roche Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Orphan Drugs Product and Services
2.5.4 Pfizer Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business
2.6.3 Sanofi Orphan Drugs Product and Services
2.6.4 Sanofi Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Alexion Pharmaceuticals
2.7.1 Alexion Pharmaceuticals Details
2.7.2 Alexion Pharmaceuticals Major Business
2.7.3 Alexion Pharmaceuticals Orphan Drugs Product and Services
2.7.4 Alexion Pharmaceuticals Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Eli Lilly and Company
2.8.1 Eli Lilly and Company Details
2.8.2 Eli Lilly and Company Major Business
2.8.3 Eli Lilly and Company Orphan Drugs Product and Services
2.8.4 Eli Lilly and Company Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Novo Nordisk
2.9.1 Novo Nordisk Details
2.9.2 Novo Nordisk Major Business
2.9.3 Novo Nordisk Orphan Drugs Product and Services
2.9.4 Novo Nordisk Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 AstraZeneca
2.10.1 AstraZeneca Details
2.10.2 AstraZeneca Major Business
2.10.3 AstraZeneca Orphan Drugs Product and Services
2.10.4 AstraZeneca Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Eisai
2.11.1 Eisai Details
2.11.2 Eisai Major Business
2.11.3 Eisai Orphan Drugs Product and Services
2.11.4 Eisai Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Daiichi Sankyo Company
2.12.1 Daiichi Sankyo Company Details
2.12.2 Daiichi Sankyo Company Major Business
2.12.3 Daiichi Sankyo Company Orphan Drugs Product and Services
2.12.4 Daiichi Sankyo Company Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Bayer
2.13.1 Bayer Details
2.13.2 Bayer Major Business
2.13.3 Bayer Orphan Drugs Product and Services
2.13.4 Bayer Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 GlaxoSmithKline
2.14.1 GlaxoSmithKline Details
2.14.2 GlaxoSmithKline Major Business
2.14.3 GlaxoSmithKline Orphan Drugs Product and Services
2.14.4 GlaxoSmithKline Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Merck & Co
2.15.1 Merck & Co Details
2.15.2 Merck & Co Major Business
2.15.3 Merck & Co Orphan Drugs Product and Services
2.15.4 Merck & Co Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Johnson & Johnson
2.16.1 Johnson & Johnson Details
2.16.2 Johnson & Johnson Major Business
2.16.3 Johnson & Johnson Orphan Drugs Product and Services
2.16.4 Johnson & Johnson Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Biogen
2.17.1 Biogen Details
2.17.2 Biogen Major Business
2.17.3 Biogen Orphan Drugs Product and Services
2.17.4 Biogen Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Takeda
2.18.1 Takeda Details
2.18.2 Takeda Major Business
2.18.3 Takeda Orphan Drugs Product and Services
2.18.4 Takeda Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Amgen
2.19.1 Amgen Details
2.19.2 Amgen Major Business
2.19.3 Amgen Orphan Drugs Product and Services
2.19.4 Amgen Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Orphan Drugs Breakdown Data by Manufacturer
3.1 Global Orphan Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Orphan Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Orphan Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Orphan Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Orphan Drugs Manufacturer Market Share in 2021
3.5 Global Orphan Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Orphan Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Orphan Drugs Market Size by Region
4.1.1 Global Orphan Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Orphan Drugs Revenue by Region (2017-2028)
4.2 North America Orphan Drugs Revenue (2017-2028)
4.3 Europe Orphan Drugs Revenue (2017-2028)
4.4 Asia-Pacific Orphan Drugs Revenue (2017-2028)
4.5 South America Orphan Drugs Revenue (2017-2028)
4.6 Middle East and Africa Orphan Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Orphan Drugs Sales in Volume by Type (2017-2028)
5.2 Global Orphan Drugs Revenue by Type (2017-2028)
5.3 Global Orphan Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Orphan Drugs Sales in Volume by Application (2017-2028)
6.2 Global Orphan Drugs Revenue by Application (2017-2028)
6.3 Global Orphan Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Orphan Drugs Sales by Type (2017-2028)
7.2 North America Orphan Drugs Sales by Application (2017-2028)
7.3 North America Orphan Drugs Market Size by Country
7.3.1 North America Orphan Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Orphan Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Orphan Drugs Sales by Type (2017-2028)
8.2 Europe Orphan Drugs Sales by Application (2017-2028)
8.3 Europe Orphan Drugs Market Size by Country
8.3.1 Europe Orphan Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Orphan Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Orphan Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Orphan Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Orphan Drugs Market Size by Region
9.3.1 Asia-Pacific Orphan Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Orphan Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Orphan Drugs Sales by Type (2017-2028)
10.2 South America Orphan Drugs Sales by Application (2017-2028)
10.3 South America Orphan Drugs Market Size by Country
10.3.1 South America Orphan Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Orphan Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Orphan Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Orphan Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Orphan Drugs Market Size by Country
11.3.1 Middle East & Africa Orphan Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Orphan Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Orphan Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Orphan Drugs
12.3 Orphan Drugs Production Process
12.4 Orphan Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Orphan Drugs Typical Distributors
13.3 Orphan Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Orphan Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Orphan Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Orphan Drugs Product and Services
Table 6. Novartis Orphan Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 8. Bristol-Myers Squibb Company Major Business
Table 9. Bristol-Myers Squibb Company Orphan Drugs Product and Services
Table 10. Bristol-Myers Squibb Company Orphan Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Celgene Basic Information, Manufacturing Base and Competitors
Table 12. Celgene Major Business
Table 13. Celgene Orphan Drugs Product and Services
Table 14. Celgene Orphan Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 16. F. Hoffmann-La Roche Major Business
Table 17. F. Hoffmann-La Roche Orphan Drugs Product and Services
Table 18. F. Hoffmann-La Roche Orphan Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Pfizer Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Major Business
Table 21. Pfizer Orphan Drugs Product and Services
Table 22. Pfizer Orphan Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Sanofi Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi Major Business
Table 25. Sanofi Orphan Drugs Product and Services
Table 26. Sanofi Orphan Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Alexion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 28. Alexion Pharmaceuticals Major Business
Table 29. Alexion Pharmaceuticals Orphan Drugs Product and Services
Table 30. Alexion Pharmaceuticals Orphan Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 32. Eli Lilly and Company Major Business
Table 33. Eli Lilly and Company Orphan Drugs Product and Services
Table 34. Eli Lilly and Company Orphan Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 36. Novo Nordisk Major Business
Table 37. Novo Nordisk Orphan Drugs Product and Services
Table 38. Novo Nordisk Orphan Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 40. AstraZeneca Major Business
Table 41. AstraZeneca Orphan Drugs Product and Services
Table 42. AstraZeneca Orphan Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Eisai Basic Information, Manufacturing Base and Competitors
Table 44. Eisai Major Business
Table 45. Eisai Orphan Drugs Product and Services
Table 46. Eisai Orphan Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Daiichi Sankyo Company Basic Information, Manufacturing Base and Competitors
Table 48. Daiichi Sankyo Company Major Business
Table 49. Daiichi Sankyo Company Orphan Drugs Product and Services
Table 50. Daiichi Sankyo Company Orphan Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Bayer Basic Information, Manufacturing Base and Competitors
Table 52. Bayer Major Business
Table 53. Bayer Orphan Drugs Product and Services
Table 54. Bayer Orphan Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 56. GlaxoSmithKline Major Business
Table 57. GlaxoSmithKline Orphan Drugs Product and Services
Table 58. GlaxoSmithKline Orphan Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Merck & Co Basic Information, Manufacturing Base and Competitors
Table 60. Merck & Co Major Business
Table 61. Merck & Co Orphan Drugs Product and Services
Table 62. Merck & Co Orphan Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 64. Johnson & Johnson Major Business
Table 65. Johnson & Johnson Orphan Drugs Product and Services
Table 66. Johnson & Johnson Orphan Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Biogen Basic Information, Manufacturing Base and Competitors
Table 68. Biogen Major Business
Table 69. Biogen Orphan Drugs Product and Services
Table 70. Biogen Orphan Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Takeda Basic Information, Manufacturing Base and Competitors
Table 72. Takeda Major Business
Table 73. Takeda Orphan Drugs Product and Services
Table 74. Takeda Orphan Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Amgen Basic Information, Manufacturing Base and Competitors
Table 76. Amgen Major Business
Table 77. Amgen Orphan Drugs Product and Services
Table 78. Amgen Orphan Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Global Orphan Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 80. Global Orphan Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 81. Market Position of Manufacturers in Orphan Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 82. Global Orphan Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 83. Head Office and Orphan Drugs Production Site of Key Manufacturer
Table 84. Orphan Drugs New Entrant and Capacity Expansion Plans
Table 85. Orphan Drugs Mergers & Acquisitions in the Past Five Years
Table 86. Global Orphan Drugs Sales by Region (2017-2022) & (K Units)
Table 87. Global Orphan Drugs Sales by Region (2023-2028) & (K Units)
Table 88. Global Orphan Drugs Revenue by Region (2017-2022) & (USD Million)
Table 89. Global Orphan Drugs Revenue by Region (2023-2028) & (USD Million)
Table 90. Global Orphan Drugs Sales by Type (2017-2022) & (K Units)
Table 91. Global Orphan Drugs Sales by Type (2023-2028) & (K Units)
Table 92. Global Orphan Drugs Revenue by Type (2017-2022) & (USD Million)
Table 93. Global Orphan Drugs Revenue by Type (2023-2028) & (USD Million)
Table 94. Global Orphan Drugs Price by Type (2017-2022) & (USD/Unit)
Table 95. Global Orphan Drugs Price by Type (2023-2028) & (USD/Unit)
Table 96. Global Orphan Drugs Sales by Application (2017-2022) & (K Units)
Table 97. Global Orphan Drugs Sales by Application (2023-2028) & (K Units)
Table 98. Global Orphan Drugs Revenue by Application (2017-2022) & (USD Million)
Table 99. Global Orphan Drugs Revenue by Application (2023-2028) & (USD Million)
Table 100. Global Orphan Drugs Price by Application (2017-2022) & (USD/Unit)
Table 101. Global Orphan Drugs Price by Application (2023-2028) & (USD/Unit)
Table 102. North America Orphan Drugs Sales by Country (2017-2022) & (K Units)
Table 103. North America Orphan Drugs Sales by Country (2023-2028) & (K Units)
Table 104. North America Orphan Drugs Revenue by Country (2017-2022) & (USD Million)
Table 105. North America Orphan Drugs Revenue by Country (2023-2028) & (USD Million)
Table 106. North America Orphan Drugs Sales by Type (2017-2022) & (K Units)
Table 107. North America Orphan Drugs Sales by Type (2023-2028) & (K Units)
Table 108. North America Orphan Drugs Sales by Application (2017-2022) & (K Units)
Table 109. North America Orphan Drugs Sales by Application (2023-2028) & (K Units)
Table 110. Europe Orphan Drugs Sales by Country (2017-2022) & (K Units)
Table 111. Europe Orphan Drugs Sales by Country (2023-2028) & (K Units)
Table 112. Europe Orphan Drugs Revenue by Country (2017-2022) & (USD Million)
Table 113. Europe Orphan Drugs Revenue by Country (2023-2028) & (USD Million)
Table 114. Europe Orphan Drugs Sales by Type (2017-2022) & (K Units)
Table 115. Europe Orphan Drugs Sales by Type (2023-2028) & (K Units)
Table 116. Europe Orphan Drugs Sales by Application (2017-2022) & (K Units)
Table 117. Europe Orphan Drugs Sales by Application (2023-2028) & (K Units)
Table 118. Asia-Pacific Orphan Drugs Sales by Region (2017-2022) & (K Units)
Table 119. Asia-Pacific Orphan Drugs Sales by Region (2023-2028) & (K Units)
Table 120. Asia-Pacific Orphan Drugs Revenue by Region (2017-2022) & (USD Million)
Table 121. Asia-Pacific Orphan Drugs Revenue by Region (2023-2028) & (USD Million)
Table 122. Asia-Pacific Orphan Drugs Sales by Type (2017-2022) & (K Units)
Table 123. Asia-Pacific Orphan Drugs Sales by Type (2023-2028) & (K Units)
Table 124. Asia-Pacific Orphan Drugs Sales by Application (2017-2022) & (K Units)
Table 125. Asia-Pacific Orphan Drugs Sales by Application (2023-2028) & (K Units)
Table 126. South America Orphan Drugs Sales by Country (2017-2022) & (K Units)
Table 127. South America Orphan Drugs Sales by Country (2023-2028) & (K Units)
Table 128. South America Orphan Drugs Revenue by Country (2017-2022) & (USD Million)
Table 129. South America Orphan Drugs Revenue by Country (2023-2028) & (USD Million)
Table 130. South America Orphan Drugs Sales by Type (2017-2022) & (K Units)
Table 131. South America Orphan Drugs Sales by Type (2023-2028) & (K Units)
Table 132. South America Orphan Drugs Sales by Application (2017-2022) & (K Units)
Table 133. South America Orphan Drugs Sales by Application (2023-2028) & (K Units)
Table 134. Middle East & Africa Orphan Drugs Sales by Region (2017-2022) & (K Units)
Table 135. Middle East & Africa Orphan Drugs Sales by Region (2023-2028) & (K Units)
Table 136. Middle East & Africa Orphan Drugs Revenue by Region (2017-2022) & (USD Million)
Table 137. Middle East & Africa Orphan Drugs Revenue by Region (2023-2028) & (USD Million)
Table 138. Middle East & Africa Orphan Drugs Sales by Type (2017-2022) & (K Units)
Table 139. Middle East & Africa Orphan Drugs Sales by Type (2023-2028) & (K Units)
Table 140. Middle East & Africa Orphan Drugs Sales by Application (2017-2022) & (K Units)
Table 141. Middle East & Africa Orphan Drugs Sales by Application (2023-2028) & (K Units)
Table 142. Orphan Drugs Raw Material
Table 143. Key Manufacturers of Orphan Drugs Raw Materials
Table 144. Direct Channel Pros & Cons
Table 145. Indirect Channel Pros & Cons
Table 146. Orphan Drugs Typical Distributors
Table 147. Orphan Drugs Typical Customers
List of Figures
Figure 1. Orphan Drugs Picture
Figure 2. Global Orphan Drugs Revenue Market Share by Type in 2021
Figure 3. Oncology
Figure 4. Gastrointestinal
Figure 5. Pulmonary
Figure 6. Neurology
Figure 7. Hematology
Figure 8. Cardio-vascular
Figure 9. Metabolic Disorders
Figure 10. Endocrinology
Figure 11. Infectious Diseases
Figure 12. Others
Figure 13. Global Orphan Drugs Revenue Market Share by Application in 2021
Figure 14. Hospital Pharmacies
Figure 15. Retail pharmacies
Figure 16. Others
Figure 17. Global Orphan Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 18. Global Orphan Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 19. Global Orphan Drugs Sales (2017-2028) & (K Units)
Figure 20. Global Orphan Drugs Price (2017-2028) & (USD/Unit)
Figure 21. Global Orphan Drugs Production Capacity (2017-2028) & (K Units)
Figure 22. Global Orphan Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 23. Orphan Drugs Market Drivers
Figure 24. Orphan Drugs Market Restraints
Figure 25. Orphan Drugs Market Trends
Figure 26. Global Orphan Drugs Sales Market Share by Manufacturer in 2021
Figure 27. Global Orphan Drugs Revenue Market Share by Manufacturer in 2021
Figure 28. Orphan Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 29. Top 3 Orphan Drugs Manufacturer (Revenue) Market Share in 2021
Figure 30. Top 6 Orphan Drugs Manufacturer (Revenue) Market Share in 2021
Figure 31. Global Orphan Drugs Sales Market Share by Region (2017-2028)
Figure 32. Global Orphan Drugs Revenue Market Share by Region (2017-2028)
Figure 33. North America Orphan Drugs Revenue (2017-2028) & (USD Million)
Figure 34. Europe Orphan Drugs Revenue (2017-2028) & (USD Million)
Figure 35. Asia-Pacific Orphan Drugs Revenue (2017-2028) & (USD Million)
Figure 36. South America Orphan Drugs Revenue (2017-2028) & (USD Million)
Figure 37. Middle East & Africa Orphan Drugs Revenue (2017-2028) & (USD Million)
Figure 38. Global Orphan Drugs Sales Market Share by Type (2017-2028)
Figure 39. Global Orphan Drugs Revenue Market Share by Type (2017-2028)
Figure 40. Global Orphan Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 41. Global Orphan Drugs Sales Market Share by Application (2017-2028)
Figure 42. Global Orphan Drugs Revenue Market Share by Application (2017-2028)
Figure 43. Global Orphan Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 44. North America Orphan Drugs Sales Market Share by Type (2017-2028)
Figure 45. North America Orphan Drugs Sales Market Share by Application (2017-2028)
Figure 46. North America Orphan Drugs Sales Market Share by Country (2017-2028)
Figure 47. North America Orphan Drugs Revenue Market Share by Country (2017-2028)
Figure 48. United States Orphan Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Canada Orphan Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Mexico Orphan Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Europe Orphan Drugs Sales Market Share by Type (2017-2028)
Figure 52. Europe Orphan Drugs Sales Market Share by Application (2017-2028)
Figure 53. Europe Orphan Drugs Sales Market Share by Country (2017-2028)
Figure 54. Europe Orphan Drugs Revenue Market Share by Country (2017-2028)
Figure 55. Germany Orphan Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. France Orphan Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. United Kingdom Orphan Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Russia Orphan Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Italy Orphan Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Asia-Pacific Orphan Drugs Sales Market Share by Region (2017-2028)
Figure 61. Asia-Pacific Orphan Drugs Sales Market Share by Application (2017-2028)
Figure 62. Asia-Pacific Orphan Drugs Sales Market Share by Region (2017-2028)
Figure 63. Asia-Pacific Orphan Drugs Revenue Market Share by Region (2017-2028)
Figure 64. China Orphan Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Japan Orphan Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Korea Orphan Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. India Orphan Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Southeast Asia Orphan Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Australia Orphan Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. South America Orphan Drugs Sales Market Share by Type (2017-2028)
Figure 71. South America Orphan Drugs Sales Market Share by Application (2017-2028)
Figure 72. South America Orphan Drugs Sales Market Share by Country (2017-2028)
Figure 73. South America Orphan Drugs Revenue Market Share by Country (2017-2028)
Figure 74. Brazil Orphan Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Argentina Orphan Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Middle East & Africa Orphan Drugs Sales Market Share by Type (2017-2028)
Figure 77. Middle East & Africa Orphan Drugs Sales Market Share by Application (2017-2028)
Figure 78. Middle East & Africa Orphan Drugs Sales Market Share by Region (2017-2028)
Figure 79. Middle East & Africa Orphan Drugs Revenue Market Share by Region (2017-2028)
Figure 80. Turkey Orphan Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Egypt Orphan Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Saudi Arabia Orphan Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. South Africa Orphan Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. Manufacturing Cost Structure Analysis of Orphan Drugs in 2021
Figure 85. Manufacturing Process Analysis of Orphan Drugs
Figure 86. Orphan Drugs Industrial Chain
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
Figure 88. Methodology
Figure 89. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
